相关实验视频

Updated: Jun 23, 2025

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults

Published on: April 22, 2022

石榴聚普尼卡拉基因作为减轻轻度认知障碍的营养药:有益特性概述

Wenjun Wang¹, Pan Long², Mengshan He³

¹State Key Laboratory of Southwestern Chinese Medicine Resources, School of Ethnic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, China; Department of Ophthalmology, The General Hospital of Western Theater Command, Chengdu, 610000, China.

European journal of pharmacology

|June 19, 2024

概括

榴中的多素Punicalagin,通过向神经炎症和氧化损伤,在预防和治疗轻度认知障碍 (MCI) 中表现有前途. 需要进一步的临床试验来确认它对这种疾病的治疗潜力.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
营养学科学营养学科学

背景情况:

由于人口老龄化,痴呆症是一个日益严重的全球健康问题.
轻度认知障碍 (MCI) 是痴呆症的前体,需要采取预防策略.
榴中的聚烯Punicalagin正在成为一种潜在的营养药物,用于认知健康.

研究的目的:

综合审查punicalagin在预防和治疗MCI中的特性和潜力.
阐明普尼卡拉对认知功能的影响背后的机制.
评估punicalagin对MCI的安全性和治疗潜力.

主要方法:

关于punicalagin和MCI的临床前和临床研究的审查.
对punicalagin的物理化学特性,来源和药理动力学的分析.
检查拟议的作用机制,包括抗氧化和抗神经炎症作用.

主要成果:

普尼卡拉在向和增强MCI治疗方面显示出潜力.
机制包括减少氧化损伤,抑制神经炎症,促进神经发生,调节神经递质.
临床前和临床证据表明,punicalagin是MCI的安全治疗化合物.

结论:

普尼卡拉在预防和治疗MCI方面显示出显著的治疗潜力.
它的多方面的机制为认知健康提供了一个有前途的方法.
需要更大,更严格的随机对照试验来验证这些发现.

关键词:

轻度认知障碍轻度认知障碍聚醇是一种多的化合物.在Punicalagin中使用.

更多相关视频

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Extraction and Purification of Polyphenols from Freeze-dried Berry Powder for the Treatment of Vascular Smooth Muscle Cells In Vitro

Published on: July 5, 2017

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

相关概念视频

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...